• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗高血压治疗对冠状动脉疾病的影响:未来研究方向

Effects of antihypertensive treatment on coronary artery disease: directions for future research.

作者信息

MacMahon S

机构信息

Department of Medicine, University of Auckland, New Zealand.

出版信息

J Cardiovasc Pharmacol. 1991;18 Suppl 2:S59-63.

PMID:1725045
Abstract

Previous trials have shown that a 5-6 mm Hg reduction in diastolic blood pressure produced by antihypertensive treatment (mainly diuretics) reduces the risk of coronary artery disease (CAD) by 14% SD5 (2p less than 0.01). However, the 95% confidence limits for this estimate of treatment effect are wide and consistent, with true reductions as small as 4% or as large as 22%. For this reason, it is not possible to determine whether the treatment benefit is of a worthwhile magnitude. Because CAD remains the leading cause of death in hypertensive patients (and normotensive patients) in most Western populations, further studies are required to determine more precisely the effect of blood pressure reduction on the incidence of CAD. This could be achieved by further large-scale studies comparing antihypertensive treatment with no treatment. It could also be achieved by comparing the effects of more and less intensive antihypertensive treatment regimens. Additional relevant information might also be generated by studies comparing the effects on CAD of new classes of antihypertensive drugs (such as angiotensin-converting enzyme inhibitors and calcium antagonists) with those of older classes (in particular diuretics). In all such studies, the detection of plausible treatment effects or of plausible treatment differences requires the recruitment of large study populations with follow-up continued for several years. This is only feasible if study methods are kept simple to insure the widest possible collaboration.

摘要

先前的试验表明,降压治疗(主要是利尿剂)使舒张压降低5 - 6毫米汞柱可使冠状动脉疾病(CAD)风险降低14%(标准差5,P值小于0.01)。然而,该治疗效果估计值的95%置信区间很宽且具有一致性,真实降低幅度小至4%或大至22%。因此,无法确定治疗益处是否具有值得追求的程度。由于在大多数西方人群中,CAD仍是高血压患者(以及血压正常者)的主要死因,所以需要进一步研究以更精确地确定血压降低对CAD发病率的影响。这可以通过进一步的大规模研究来实现,即比较降压治疗与不治疗的效果。也可以通过比较强化程度不同的降压治疗方案的效果来实现。比较新型降压药物(如血管紧张素转换酶抑制剂和钙拮抗剂)与旧型药物(特别是利尿剂)对CAD的影响的研究,可能也会产生其他相关信息。在所有此类研究中,要检测出合理的治疗效果或合理的治疗差异,需要招募大量研究人群并持续随访数年。只有在研究方法保持简单以确保尽可能广泛的合作时,这才可行。

相似文献

1
Effects of antihypertensive treatment on coronary artery disease: directions for future research.抗高血压治疗对冠状动脉疾病的影响:未来研究方向
J Cardiovasc Pharmacol. 1991;18 Suppl 2:S59-63.
2
[Retrospective studies and prospects of therapy for hypertension].[高血压治疗的回顾性研究与展望]
Herz. 1995 Dec;20(6):370-89.
3
The future of antihypertensive treatment.抗高血压治疗的未来。
Am J Ther. 2007 Mar-Apr;14(2):121-34. doi: 10.1097/01.pap.0000249915.12185.58.
4
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.降血压治疗主要随机试验的前瞻性协作综述方案。世界卫生组织 - 国际高血压学会降血压治疗试验协作组
J Hypertens. 1998 Feb;16(2):127-37.
5
Future directions for randomized trials of cardiovascular disease prevention in hypertensive patients.高血压患者心血管疾病预防随机试验的未来方向
J Cardiovasc Pharmacol. 1990;16 Suppl 7:S96-9.
6
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?肾素-血管紧张素系统抑制对靶器官保护的作用:我们能否做得更好?
Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019.
7
Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.抗高血压药物治疗对痴呆症和认知障碍风险的影响。
Pharmacotherapy. 2008 Mar;28(3):366-75. doi: 10.1592/phco.28.3.366.
8
[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].[心血管疾病中的钙拮抗剂。发病率和死亡率试验的临床证据]
Drugs. 2000;59 Spec No 2:25-37.
9
Blood pressure and coronary heart disease: a review of the evidence.血压与冠心病:证据综述
Semin Vasc Med. 2002 Nov;2(4):355-68. doi: 10.1055/s-2002-36765.
10
[Are all antihypertensive drugs renoprotective?].[所有抗高血压药物都具有肾脏保护作用吗?]
Herz. 2004 May;29(3):248-54. doi: 10.1007/s00059-003-2508-6.